Researchers performed a systematic review and meta-analysis to summarize and update the evidence regarding the effects of lifestyle intervention, including diet, on cardiometabolic risk among overweight and obese women with PCOS.
The study authors theorized that the interplay between inflammation and cytokines may influence mood and behavioral disturbances, which could explain the overlap between PCOS and bipolar disorder.
Faster increases in bone turnover during the menopausal transition are associated with an increased risk for fracture postmenopause.
The majority of women experience symptoms and health concerns associated with menopause, but more than one-third never discuss these concerns with health care providers.
For postmenopausal women, conjugated equine estrogen alone is associated with a long-term decrease in breast cancer incidence, while CEE plus medroxyprogesterone acetate is associated with increased incidence.
Postmenopausal women more often have sleep-onset insomnia disorder and are more likely to screen positive for obstructive sleep apnea.
Compared with injectable contraceptive norethisterone enanthate and combined oral contraceptive pills, contraceptive vaginal ring lowered cervical frequencies of Th17 cells, which may affect HIV risk stratification.
Compared to nonhormonal contraception, hormonal contraception appears to pose a greater risk for increased seizure frequency in women with epilepsy.
The vaginal ring releases on average 0.12mg/d of etonogestrel, a progestin, and 0.015mg/d of ethinyl estradiol, an estrogen.
Linzagolix is a novel, oral gonadotropin-releasing hormone (GnRH) receptor antagonist, the trial assessed the treatment in 535 women.
